Gene · 839
Papers3,659
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,659
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New progress in understanding roles of nitric oxide during hepatic ischemia-reperfusion injury. | World J Hepatol | 2022 | 35582289 | PubTator, text mining | PubMed |
| Mesenchymal stromal cell-derived extracellular vesicles: novel approach in hematopoietic stem cell transplantation. | Stem Cell Res Ther | 2022 | 35578300 | PubTator, text mining | PubMed |
| A Pyroptosis-Related Gene Panel for Predicting the Prognosis and Immune Microenvironment of Cervical Cancer. | Front Oncol | 2022 | 35574296 | PubTator, text mining | PubMed |
| Excess DHA Induces Liver Injury via Lipid Peroxidation and Gut Microbiota-Derived Lipopolysaccharide in Zebrafish. | Front Nutr | 2022 | 35571918 | PubTator, text mining | PubMed |
| Pyroptosis-Related Gene Signature and Expression Patterns in the Deterioration of Atherosclerosis. | Dis Markers | 2022 | 35571620 | PubTator, text mining | PubMed |
| Sustainable competitive advantage in maternal and child health institutions: a dynamic capability approach. | Ann Oper Res | 2022 | 35571380 | PubTator, text mining | PubMed |
| Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer. | Front Genet | 2022 | 35571063 | PubTator, text mining | PubMed |
| TGIF1 overexpression promotes glioma progression and worsens patient prognosis. | Cancer Med | 2022 | 35569122 | PubTator, text mining | PubMed |
| A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma. | Cancer Med | 2022 | 35567376 | PubTator, text mining | PubMed |
| Combinatorial Delivery of Gallium (III) Nitrate and Curcumin Complex-Loaded Hollow Mesoporous Silica Nanoparticles for Breast Cancer Treatment. | Nanomaterials (Basel) | 2022 | 35564180 | PubTator, text mining | PubMed |
| It's All in the PAN: Crosstalk, Plasticity, Redundancies, Switches, and Interconnectedness Encompassed by PANoptosis Underlying the Totality of Cell Death-Associated Biological Effects. | Cells | 2022 | 35563804 | PubTator, text mining | PubMed |
| Evolutionary Diversity and Function of Metacaspases in Plants: Similar to but Not Caspases. | Int J Mol Sci | 2022 | 35562978 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma. | Front Genet | 2022 | 35559014 | PubTator, text mining | PubMed |
| Pyroptosis-Related Patterns Predict Tumor Immune Landscape and Immunotherapy Response in Bladder Cancer. | Front Mol Biosci | 2022 | 35558555 | PubTator, text mining | PubMed |
| Brain region-specific effects of nearly fixed sapiens-derived alleles. | BMC Genom Data | 2022 | 35546225 | PubTator, text mining | PubMed |
| Dapsone is an anticatalysis for Alzheimer's disease exacerbation. | iScience | 2022 | 35542045 | PubTator, text mining | PubMed |
| HIVEP3 cooperates with ferroptosis gene signatures to confer adverse prognosis in acute myeloid leukemia. | Cancer Med | 2022 | 35535739 | PubTator, text mining | PubMed |
| Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma. | Dis Markers | 2022 | 35535333 | PubTator, text mining | PubMed |
| The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context. | Front Oncol | 2022 | 35530337 | PubTator, text mining | PubMed |
| Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach. | Avicenna J Med Biotechnol | 2022 | 35509362 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/839/papers?page=33